CIK 0001386570
- Large accelerated filer
Niagen Bioscience, Inc.
Sign in to watch- Ticker
- NAGE
- Exchange
- Nasdaq
- Industry
- Medicinal Chemicals & Botanical Products
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262940963
- Phone
- +1 310-388-6706
- Business address
- 10900 WILSHIRE BLVD, SUITE 600, LOS ANGELES, CA, 90024
- Former names
- ChromaDex Corp., CODY RESOURCES, INC.
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Exercise or conversion Chief Executive Officer acquired 66,667 shares (option exercise)
- 4 Open-market buy SVP, General Counsel bought 273 shares at $7.86 ($2,146)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Director sold 37,161 shares at $6.19 ($229,956)
- 4 Open-market buy Chief Financial Officer bought 2,907.2 shares at $7.36 ($21,397)
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Director sold 23,000 shares at $3.57 ($82,110)
- 4 Open-market sale 10% owner sold 11,408,715 shares
- 4 Open-market buy 10% owner bought 11,408,715 shares
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 2 of 20 · 384 filings